Amgen
AMGN
$236.76
Share price
-0.53%
Change (1 day)
-1.54%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Revenue for Amgen (AMGN)
Revenue in 2022 (TTM): $26.32 B
According to Amgen's latest financial reports the company's current revenue (TTM) is $26.32 B. In 2021 the company made a revenue of $25.97 B an increase over the years 2020 revenue that were of $25.42 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amgen from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $26.32 B | 1.32% |
| 2021 | $25.97 B | 2.18% |
| 2020 | $25.42 B | 8.83% |
| 2019 | $23.36 B | -1.62% |
| 2018 | $23.74 B | 3.93% |
| 2017 | $22.84 B | -0.62% |
| 2016 | $22.99 B | 6.14% |
| 2015 | $21.66 B | 7.97% |
| 2014 | $20.06 B | 7.43% |
| 2013 | $18.67 B | 8.17% |
| 2012 | $17.26 B | 10.8% |
| 2011 | $15.58 B | 3.51% |
| 2010 | $15.05 B | 2.81% |
| 2009 | $14.64 B | -2.41% |
| 2008 | $15.00 B | 1.57% |
| 2007 | $14.77 B | 3.53% |
| 2006 | $14.26 B | 14.79% |
| 2005 | $12.43 B | 17.82% |
| 2004 | $10.54 B | 26.26% |
| 2003 | $8.35 B | 53.52% |
| 2002 | $5.44 B | 35.54% |
| 2001 | $4.01 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.94 B | 260.68% | 🇺🇸 USA |
 Pfizer PFE | $100.33 B | 281.15% | 🇺🇸 USA |
 AbbVie ABBV | $58.05 B | 120.54% | 🇺🇸 USA |
 Eli Lilly LLY | $28.54 B | 8.43% | 🇺🇸 USA |
 Biogen BIIB | $10.17 B | -61.35% | 🇺🇸 USA |
 Gilead Sciences GILD | $27.28 B | 3.64% | 🇺🇸 USA |
 Illumina ILMN | $4.58 B | -82.59% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $46.15 B | 75.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $38.94 B | 47.93% | 🇬🇧 UK |